AGP Picks
View all

Asia Pacific News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Journal.

Press releases published on April 14, 2026

EZVIZ zet volgende stap in slimme schoonmaak op Interclean
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
GCL’s 4Divinity Inks Asia-Wide (Excluding Japan) Distribution and Publishing Agreement with Developer of ‘Windrose’
Taseko Updates Florence Copper and Gibraltar First Quarter Production
Ruanyun Edai Technology Enters MOU with City University Malaysia to Advance Global Education Strategy and Planned Transition to Formind Group
XMPro Named as a Sample Vendor in Two Categories of the 2026 Gartner® Hype Cycle™ for Agentic AI
Luxury Tribe India 2026: Australia Matures, China Reframed in India's Outbound Luxury Conversation
Off-Market Property Deals Rise Across Australia as Buyers Navigate Tighter Supply and Increased Competition
Poposoap Unveils 2030 Sustainability Roadmap and International Expansion
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
Rivus Pharmaceuticals Announces First Patients Dosed in AMPLIFY Phase 2 Trial for HU6 in MASH
Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts
CHEERS Telepathy Introduces New AI Translation Capabilities and Global AI Assistant in Latest Release
Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One
NevGold Announces Positive, Consistent Drill Results on Historic Gold Leach Pads Including 0.34% Antimony And 0.41 g/t Au Over 12.5 Meters; Path to Near-Term Antimony Production Continues
Tims China Announces Fourth Quarter and Full Year 2025 Financial Results
Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
XCharge to Participate in the Webull Corporate Connect Webinar Series for Clean Energy Sector on April 15, 2026
Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor

Share this page:

Sign up for:

Asia Pacific News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.